Viewing Study NCT00094367


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-04-13 @ 7:48 AM
Study NCT ID: NCT00094367
Status: COMPLETED
Last Update Posted: 2010-09-30
First Post: 2004-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module